Is this you?
Request access for Core Clinical Trials with your @coreclinicaltrials.co work email. Intera will contact you to verify and set up your account — nothing auto-publishes.
Core Clinical Trials
Unclaimed profileHybrid · Newport Beach, CA · ~800+ sites
Intera lens
ICP 8Lift (cardio sample) 0.44Recruit soph 0.43
Quality Scorecard (1–100)
Overall72Recruit66Ops81Sponsor69Ther71
Performance (observed)
Historical trials
220
Completed
138
Terminated/Withdrawn
21
Completion rate
87%
Active now
58
Phase 2
60
Phase 3
138
Realized enrollment
363,189
First study year
1999
Years active
27
Match confidence
low
Enrollment velocity (inf)
13,451
Therapeutic
Areas
Broad multi-specialty: Cardiology, Internal Medicine, Family Practice, Dermatology, Neurology, Infectious Disease, Dental, Pain Medicine, Podiatry
Specialties
Gastroenterology, Ophthalmology, Neurology & Psychiatry, Allergy & Immunology, Dermatology, Women's Health, Cardiology, Endocrinology, Rheumatology, Pulmonology, Phase 1, Alzheimer's, Psychedelic Research
Breadth (conditions)
158
States
Multi-state
Recruitment (web observed)
Trial Finder
Yes
Recruitment pages
Yes
Advertises recruitment
Yes
SEO
Y - strong presence with specialty pages
Capability notes
5M+ active patients; 800 board-certified physicians; rapid study startup; diverse patient population; telemedicine/virtual capability
Relationships
Sponsors
AbbVie; Eli Lilly and Company; Pfizer; National Institute of Allergy and Infectious Diseases (NIAID); Boehringer Ingelheim; Otsuka Pharmaceutical Development & Commercialization, Inc.
CROs
Worldwide Clinical Trials
Owner / parent
Unknown (founded 2015; Inc. 5000 honoree 2023)
Funding
Self-owned/Investigator-owned
Expansion
Nationwide network, rapid growth
Recent hiring
Growing (Inc. 5000 ranked #515 in 2023)
Capacity & people
Investigators
—
Coordinators
—
CEO
Michelle Alex, DPM
VP Clinical Ops
Unknown
VP Site Ops
Unknown
VP Recruitment
Unknown
Emails
info@coreclinicaltrials.co
Tech & DCT
CTMS
Proprietary TrialPulse technology (unnamed vendor)
eSource
Yes
Builds tech
Builds (Direct to Patient platform for virtual trials)
DCT / decentralized
Y - virtual trial platform
Tech stack
Direct to Patient platform (proprietary virtual trial platform)
Recruiting visible
Y
Notes
Investigator-owned ISN (not traditional SMO); 800+ board-certified physicians; 5M+ patient population; 300+ studies launched; strong DCT/virtual capability via Direct to Patient platform; good Intera fit for recruitment scale and innovation
Recommendation features (sample indication)
Ind fit 0.78Liftability 0.44Overall72
FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.